{
  "docId": "019dd923-5fed-74f2-a96f-6b553a5d9cee",
  "docSlug": "bi-b4800d178bbbc7a4",
  "documentTitle": "ImCheck Therapeutics pitch deck used to raise Series C",
  "authorId": "Pitchdecks",
  "authorName": "ImCheck Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.331,
  "pageNumber": 11,
  "pageCount": 14,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "appendix_methodology",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a process flow diagram to illustrate the clinical trial structure.",
  "elementsJson": [
    "headline_text",
    "process_diagram",
    "numbered_list"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5fed-74f2-a96f-6b553a5d9cee/11",
  "deckHref": "/decks/019dd923-5fed-74f2-a96f-6b553a5d9cee",
  "deckJsonHref": "/decks/019dd923-5fed-74f2-a96f-6b553a5d9cee.json",
  "deckAnchorHref": "/decks/019dd923-5fed-74f2-a96f-6b553a5d9cee#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.7,
        "w": 0.6,
        "x": 0.04,
        "y": 0.2
      },
      "kind": "diagram",
      "text": "Flowchart showing Part 1 (Dose Escalation) leading into Part 2 (Expansion Cohorts) for various tumor types and treatment combinations.",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "37f7f757-e6e3-454e-a59b-e046caf7d040",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.3,
        "x": 0.67,
        "y": 0.3
      },
      "kind": "list",
      "text": "Part 1 Basket Indications and Main Eligibility Criteria",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "07f27d59-cf57-4630-bf4b-da2691229093",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.3,
        "x": 0.67,
        "y": 0.75
      },
      "kind": "paragraph",
      "text": "Participating Countries: France, Belgium, Germany, Spain, the U.K. and the U.S.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f4b68655-9fa6-41d3-b6cc-0e54e7e97c5c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.04,
        "y": 0.04
      },
      "kind": "title",
      "text": "Design of EVICTION: Open-label, Phase I/IIa Study of ICT01 Monotherapy and Combination with Pembrolizumab",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "27cb44fe-5830-4a23-9b32-773ce9bf1fdf",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Process flow",
      "slug": "process-flow",
      "agent": null,
      "layer": "slide",
      "matchId": "a6bb2843-14a0-4303-8987-20310b5f6f71",
      "evidence": "Flowchart showing Part 1 (Dose Escalation) leading into Part 2 (Expansion Cohorts)",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "process",
      "slug": null,
      "matchId": "eee388bb-81ac-42d5-961b-4d8b8793d26b",
      "evidence": "The slide maps out the clinical trial progression from Part 1 to Part 2.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}